glp-1 agonist weight loss mechanism Mechanisms by which agonists may exert beneficial effects on the Top GLP-1 Agonists Balance Weight

Description

Heart failure with preserved ejection fraction (HFpEF) accounts for approximately half of all heart failure cases, with patients bearing a high symptomatic burden and physical limitations that impact their daily lives

Moreover, in DNA methylation alterations of tumor cells induced by GLP-1RAs, studies have demonstrated that during breast cancer progression, tumor suppressor genes such as ESR1, CDH1, and ADAM33 are downregulated due to hypermethylation alterations in their promoter regions

Nevertheless, factors such as supply challenges, restricted funding, high out-of-pocket costs and side effect fears could limit the uptake of the drugs, creating uncertainties around the future size and shape of demand

For additional product-specific information on agents from the GLP-1 RA class, please refer to the companion lesson titled: An Overview of GLP-1 RAs: What Every Pharmacist Should Know. PUTTING IT ALL TOGETHER: CASE REVIEW AND DISCUSSION Case scenario JM is a 65-year-old man with T2D of 8 years duration